Larimar Therapeutics, Inc. (NASDAQ:LRMR), with a market capitalization of $228 million, is a clinical-stage biopharmaceutical ...

Key Takeaways JNJ will buy Intra-Cellular Therapies, producer of a drug for bipolar disorder, for $14.6 billion. Eli Lilly ...

The FDA is reviewing new vaccines for meningitis and chikungunya and therapies for Parkinson disease and PTSD.

Daiichi Sankyo and AstraZeneca’s (AZN) biologics license application for datopotamab deruxtecan has been accepted and granted priority review ...

Kidney cancer therapy candidate, TLX250 (177Lu-girentuximab): The Company was granted a pre-investigational new drug (pre-IND) meeting with the U.S. Food and Drug Administration (FDA) in Q4 2024, to ...

The FDA accepted the revised sNDA for IZERVAY, addressing a previous Complete Response Letter from November 2024. The resubmission is classified as Class 1, with a 60-day review period, targeting a ...

The US Food and Drug Administration (FDA) has accepted the revised supplemental New Drug Application (sNDA) for IZERVAY (avacincaptad pegol intravitreal solution) for the treatment of geographic ...

Balochistan: As many as 47 security personnel were killed and more than 30 others were injured in the Baloch Liberation Army's (BLA) "Fidayee unit" Majeed Brigade's suicide attack on a Pakistani ...

Ottawa: In yet another worrying move for Indian immigrants living in Canada, the Canadian federal government has announced that it will not accept any new applications for sponsoring parents and ...

Justin Baldoni sued The New York Times over its story about Blake Lively's harassment claims. The lawsuit claims the Times relied on Lively's narrative and caused Baldoni damage. The Times ...

Germany has officially launched the Consular Services Portal, a comprehensive online platform that allows applicants to submit German visa applications digitally. This initiative, which began two ...